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Fringe proteins are O-fucose-specific h-1,3 N-acetylglucosaminyltransferases that glycosylate the extracellular EGF repeats of Notch and
enable Notch to be activated by the ligand Delta. In the sea urchin, signaling between Delta and Notch is known to be necessary for
specification of secondary mesenchyme cells (SMCs). The Lytechinus variegatus Fringe homologue is expressed in both the signaling and
receiving cells during this first Delta–Notch signal. Perturbation of Fringe expression through morpholino antisense oligonucleotide (MO)
injection results in fewer SMCs but also causes decreased and delayed archenteron invagination. Partial endoderm specification occurs but
expression of some endoderm genes is compromised. The data are consistent with a Fringe-requiring Notch signal as one upstream
component of archenteron morphogenesis. Finally, Fringe perturbations result in more severe phenotypes than those previously reported for
Notch dominant-negative (LvNneg) injections or reported here for Notch MO (NMO) injections. Injecting a combination of LvNneg and NMO
results in a more severe phenotype than either treatment alone, and this combination phenocopies the fringe MO embryos. Taken together, the
results show that Fringe is necessary both for maternal and zygotic Notch signals, and these Notch signals affect specification of mesoderm
and endoderm.
D 2005 Elsevier Inc. All rights reserved.
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The Notch signaling pathway is important for the
processes of cell specification and boundary formation
throughout development in many organisms. Originally,
identified and characterized in the wing disc of Drosophila
melanogaster, Notch signaling has since been identified as
essential for many aspects of development including axis
formation, germ layer specification, organogenesis, and
cellular differentiation (Artavanis-Tsakonas et al., 1990;
Fehon et al., 1991; Jacobsen et al., 1998; Mello et al., 1994;
Rones et al., 2000; Sherwood and McClay, 1999). The
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Chapel Hill, USA.Serrate, or Lag-2 type ligand (Fehon et al., 1990; Rebay
et al., 1991), and this interaction leads to the cytoplasmic
release of the Notch intracellular domain which translocates
to the nucleus and acts as a transcription cofactor (Baron,
2003; Iso et al., 2003; Lai, 2002; Schroeter et al., 1998).
Notch plays an early and central role in endomesoderm
specification in the sea urchin (Sherwood and McClay,
1999, 2001). Vegetal blastomeres initiate endomesoderm
specification at about 4th cleavage {Logan, 1999 #2157}
{Oliveri, 2003 #3066}. Delta is expressed by micromeres at
the vegetal pole shortly after the 6th cleavage. This
expression is coincident with the experimentally timed
reception of the Notch-activating ligand by veg2 cells,
located just above the micromeres (Fig. 1; McClay et al.,
2000; Oliveri et al., 2002; Sweet et al., 1999; Sweet et al.,
2002). The first Delta–Notch signal results in specification
of pigment cells and blastocoelar cells (Sweet et al., 2002).
Delta is expressed a second time, this time in the veg2 tier of
cells, and this later expression results in specification of282 (2005) 126–137YDBIO-01923; No. of pages: 12; 4C: 2, 7, 8, 9
Fig. 1. Overview of sea urchin morphogenesis and the role of Notch signaling. This panel represents development of the sea urchin embryo from the blastula
stage through the midgastrula stage. Cells with an ectoderm fate are represented in blue, endoderm in yellow, and mesoderm in red. Maternal Notch (green)
surrounds the blastula on the apical surface of all cells. Notch is lost from the vegetal plate after being activated there by Delta from the micromeres (arrows in
blastula). The SMCs then express Delta in a broader pattern at the vegetal plate and presumably expand the cleared SMC region (arrows at mesenchyme
blastula). At mesenchyme blastula, Notch is up-regulated on the apical surface of endoderm. Fringe is expressed by all cells of the embryo at the blastula stage,
then it is lost first from the ingressed PMCs, and later Fringe is lost from the SMCs and finally from the endoderm as it invaginates.
R.E. Peterson, D.R. McClay / Developmental Biology 282 (2005) 126–137 127more blastocoelar cells and pharyngeal muscle. Presumably,
this is a consequence of a second Delta–Notch signal
between veg2 progeny (Sweet et al., 2002). Delta continues
to be present in veg2 progeny until the mesenchyme blastula
stage, where it has the potential to signal across the SMC/
endoderm boundary (Oliveri et al., 2002; Sherwood and
McClay, 2001; Sweet et al., 2002). Support for a possible
Delta–Notch signal across the SMC/endoderm boundary
currently is largely circumstantial. Antibody staining shows
Delta on the SMC side of the boundary and Notch on the
endoderm side (Sherwood and McClay, 1997; Sweet et al.,
2002). Injection of Nact into one animal blastomere at the
eight-cell stage results in an ectopic gut or increased
contribution to the existing gut, suggesting that added
Notch signaling augments endoderm (Sherwood and
McClay, 2001). Additionally, perturbation analyses showed
that animal caps from embryos injected with Nact develop
into embryoids with differentiated endoderm, while control
animal caps gave rise only to unspecified Dauer blastulae
(Sweet et al., 2002). While the underlying signaling and its
consequences are not understood in detail relative to the
endomesoderm gene regulatory network (Davidson et al.,
2002), it is clear that Notch signaling somehow impinges on
endoderm specification.
From the above, it appears as though Notch signaling
during sea urchin cleavage occurs in a cascade of activation
events, beginning with the micromeres and continuing cell-
by-cell through the mesoderm, and perhaps into the
endoderm (Sherwood and McClay, 1999, 2001; Sweet et
al., 2002). The challenge is to parse out these sequential
Notch signaling events to determine the function of each.
One approach to meet this challenge is to examine modifiers
of Notch signaling that are known to regulate Notch
activation both spatially and temporally. Fringe is one such
modifier that glycosylates extracellular EGF-like re-
peats on Notch, functioning as an O-fucose specific h-1,3
N-acetylglucosaminyltransferase (Haltiwanger and Stanley,
2002; Moloney et al., 2000). Fringe glycosylation poten-
tiates activation of Notch by Delta and blocks any Notch
activation by Serrate (Fleming et al., 1997; Irvine andWieschaus, 1994; Panin et al., 1997). Thus, Fringe contri-
butes to the spatial and temporal patterns of Notch ac-
tivation signals by determining where each ligand can
activate Notch.
Here, Lytechinus variegatus fringe is identified and its
function studied to better understand the timing and role of
Notch activation in germ layer specification. Fringe is
required for activation of Notch during SMC specification.
Fringe is also required for a Notch signal that directly or
indirectly activates archenteron invagination while not
appearing to disrupt expression of some genes in the
endoderm gene regulatory network. The evidence also
suggests a delay in oral–aboral ectoderm specification,
most likely due to a delayed reception of required vegetal
signals.Materials and methods
Fringe cloning and sequence comparison
Degenerate primers were designed against peptides
derived from ClustalX alignments (Chenna et al., 2003) to
amino acid sequences from various Fringe homologues. A
PCR product was obtained using degenerate primers on
reverse transcribed RNA from multiple timepoints of
L. variegatus development. The product was cloned into
pGEM-T and sequenced by the Duke University Compre-
hensive Cancer Center DNA Analysis Facility (http://
www.cancer.duke.edu/dna/Sequencing).
Library screening and sequence analysis
A k-ZAP-II L. variegatus midgastrula cDNA library was
screened with the product of degenerate primer PCR. The
probe was 32P-dCTP labeled with Rediprimer II random
prime labeling kit (Amersham-Pharmacia Biotech). Screens
were performed as previously described (Gross et al., 2003).
Positive clones were excised using ExAssist into pBS-II
plasmids, which were transformed, purified, and sequenced.
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Codes Corporation) and aligned into a complete contig. A
single clone containing the entire open reading frame was
subcloned.
The contig was translated and compared to known genes
using blastx on the National Center for Biotechnology
Information (NCBI) BLAST homepage. Representative
fringe homologues were aligned with ClustalX (NCBI) and
output in a Nexus format (Jeanmougin et al., 1998; Madden
et al., 1996). The alignment was imported into PAUP 4.0b
and a consensus bootstrap analysis was done using neighbor
joining with 1000 replicates. The tree was rooted with the
invertebrate Fringe proteins. The sequences used for the
phylogram were: L. variegatus Fringe (FNG_LYTVA); N.
viridescens Radical Fringe (RFNG_NOTVI), gi-27734466;
Mouse Radical Fringe (RFNG_MOUSE), gi-27734463; Rat
Radical Fringe (RFNG_RAT), gi-27734462; Human Radical
Fringe (RFNG_HUMAN), gi-27734461; Chicken Radical
Fringe (RFNG_CHICK), gi-27734460; Human Lunatic
Fringe (L-FNG_HUMAN), gi-27734417; Zebrafish Lunatic
Fringe (L-FNG_BRARE), gi-27734416; Mouse Lunatic
Fringe (L-FNG_MOUSE), gi-27734412; Rat Lunatic Fringe
(L-Fringe_RAT), gi-27734411; Mouse Manic FNG,
(MFNG_MOUSE), gi-20138532; Human Manic Fringe
(MFNG_HUMAN), gi-20138530; D. melanogaster Fringe
(FNG_DROME), gi-2497667; Junonia coenia Fringe
(FNG_JUNCO), gi-29469035; Chicken Fringe-1 (CFNG_
CHICK), gi-7512208; Schistocerca gregaria Fringe (FNG_
SCHGR), gi-6573138; Human Lunatic Fringe-2 (L2FNG_
HUMAN), gi-15990390; Chicken Lunatic Fringe (L-
FNG_CHICK), gi-1930053; X. laevis Radical Fringe
(RFNG_XENLA), gi-27734464; and X. laevis Lunatic
Fringe (L-FNG_XENLA), gi-1679782.
Northern blot analysis and quantitative PCR
Approximately 3 mg of poly (A) mRNA isolated with
Quickprep mRNA kit (Amersham-Pharmacia Biotech) was
run on a 1% agarose/formaldehyde denaturing gel and
transferred onto MagnaGraph using a Turboblotter System
(Schleicher and Schuell). The blot was auto-irradiated in an
UV Stratalinkerk 1800 (Stratagene). The blot was hybri-
dized using standard molecular hybridization techniques
with a 32P-labeled 384-bp fragment of fringe (Church and
Gilbert, 1984). It was then stripped in 50% formamide, 6
SSPE for 30 min at 658C and reprobed as above with a
Lytechinus pictus ubiquitin fragment as a loading control
(Gross et al., 2003).
Quantitative PCR (QPCR) was performed basically as
described (Amore et al., 2003) with the following mo-
difications. Fringe primers were designed using the
LightCycler Probe Design Software, Version 1.0 (Idaho
Technology, Inc.). The primers showed a single peak
followingmelting point analysis and a single band on agarose
gel electrophoresis. The band was isolated and sequenced to
verify that it was in fact fringe. The number of cycles requiredto cross a predetermined threshold (Ct) within the linear range
of amplification was determined. The Ct for each injection
sample was normalized to the Ct of ubiquitin for the same
injection sample, which was run simultaneously [CtNORM =
CtAVE(sample)  CtAVE(ubiquitin)]. Two separate RT reac-
tions were used and several reactions were averaged for each
stage.
Antibody production and Western blot analysis
A recombinant plasmid was constructed to produce the
mature Fringe protein with a 6X-His tag in the pQE32
plasmid (QIAexpressionist, Qiagen, Inc.). The plasmid was
transformed into XL1-Blue bacterial cells, grown at 378C,
and induced with IPTG as per the manufacturer protocol.
The recombinant protein was found to be insoluble and was
purified using the manufacturer protocol for insoluble
proteins, with the addition of imidazole at 10 AM in all
buffers. The isolated protein was dialyzed into PBS, at
which time it immediately precipitated and was concen-
trated further through centrifugation. The slurry containing
insoluble protein in PBS was used for the production of
antibodies.
Recombinant Fringe protein slurry was used for injection
into Guinea pigs, mice, and chickens (the latter at Aves
Labs, Inc.). For Guinea pigs and mice, the insoluble protein
slurry was mixed 1:1 with Freund’s complete adjuvant and
injected into three Guinea pigs and five mice (Charles River,
Raleigh, NC). The schedule for Guinea pig and mice boosts
were as described (Gross et al., 2003). Two Guinea pigs and
one mouse tested positive for reactivity to the purified
recombinant protein. The two Guinea pigs were terminally
bled 10 days after the final boost and the antiserum was
frozen at 808C. Monoclonal antibodies were produced
through fusion with NS-1 myeloma cells (Harlow and Lane,
1998; McClay and Wessel, 1984). An anti-Fringe antibody
termed 1D12 was purified from total hybridoma supernatant
using an Anti-Mouse IgM Monoclonal Antibody Affinity
Isolation System (American Qualex). Chicken antiserum
was isolated and the IgY fraction purified by Aves Labs,
Inc. Two hens injected with the recombinant protein slurry
produced viable antibodies, one of which was boosted
additional times and an additional IgY fraction was purified.
Embryo fixation, staining, and confocal analysis
Embryos were reared to the desired timepoints in ASWat
a constant temperature of either 258C or 188C. Fixation was
for 15 min in either 2% paraformaldehyde/60%ASW or in
3.7% formaldehyde/60% ASW. All embryos were permea-
bilized with ice-cold 100% methanol for 1–2 min and
washed into PBS with 5% normal goat serum (PBS/NGS).
The embryos were washed three times for 15 min each in
PBS/NGS before being placed into primary antibodies.
Previously described antibodies were used at published
dilutions: 1D5, EctoV, and Endo 1 (McClay and Wessel,
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(Sherwood and McClay, 1997), rabbit anti-SoxB1 (Kenny et
al., 1999), and Guinea pig anti-h-catenin (Miller and
McClay, 1997). The new chicken-anti-Fringe, Guinea pig
anti-Fringe, and mouse monoclonal anti-Fringe were diluted
to 1:500, 1:1000, and 1:5000 respectively. Primary anti-
bodies were left on the embryos overnight at 48C. Washes
were performed in triplicate for 15 min between primary and
secondary antibody exposure. Cy2, Cy3, and Cy5 con-
jugated secondary antibodies were purchased from Jackson
Immunochemicals, Inc. and diluted to 1:200. The secondary
antibodies were left either at 258C for 1 h or overnight at
48C before being washed. Final washes were PBS/NGS
three times for 15 min, followed by increasing concen-
trations of glycerol in PBS (10%, 30%, 50%) for 15 min per
wash. Embryos were mounted in 50% glycerol under
0-thickness cover slips for confocal microscopy. Confocal
images were gathered on a Zeiss 510 Confocal System,
exported as a TIFF raw image series, analyzed, and stacked
using Zeiss 410 software.
Injection of morpholino antisense oligonucleotide
Morpholino antisense oligonucleotides (MOs) were
designed from primary sequence determinations (fringe),
or from GenBank sequence (notch; NMO), by Gene-
Tools, Inc. (Corvallis, OR). An MO (FMO) was produced
beginning at the start site with the sequence 5V-GATGA-
CTCGTTACATTGCGGAAAA-3V and was used for all
reported analyses. Control MO (CMO) is the standard
control MO designed against a mutated human splice site
in the beta-globin pre-mRNA from thalassemic human
reticulocytes (Stein et al., 1997; Summerton and Weller,
1997).
CMO, NMO, and FMO were injected at various
dilutions in 40% glycerol, 10% rhodamine dextran
(70,000 MW; RD; Molecular Probes), and ddH2O. Cell
Trackerk Green CMFDA (Molecular Probes) was added to
seawater at an approximate dilution of 1:106 to stain
uninjected embryos for transplant experiments. MOs were
brought up in sterile water to a concentration of 3 mM and
aliquots of 5 Al were frozen at 808C. Immediately before
injection, the aliquots were thawed at 658C for 5 min,
vortexed, spun down, and aliquoted to the appropriate
dilution. The stock was marked and returned immediately to
808C. The diluted MOs were again heated to 658C for 3
min, vortexed, briefly spun down, and left at room
temperature. The mRNA for LvNneg or LvNnegD were
produced from previously described clones (Sherwood and
McClay, 1999). The mRNA was mixed to a final concen-
tration of either 4.5 pg/pL (LvNneg) or 5.0 pg/pL (LvNnegD)
with room temperature NMO. The mixture was injected.
The MOs and mRNA mixtures were loaded into pulled
injection pipettes and injected into fertilized eggs or two-
cell stage embryos as described (Mao et al., 1996;
Sherwood and McClay, 1999).Microsurgery
Both injected and uninjected embryos were rinsed briefly
in calcium-free seawater and transferred to a modified
Kiehart chamber (Kiehart, 1982). The embryos were mani-
pulated with two glass needles, one serving as a suction
pipette and the other serving as a maneuvering device. In all
transplants, the treated embryos were stained red with
Rhodamine Dextran, while the control embryos were stained
green with Cell Trackerk Green CMFDA (Molecular
Probes, Inc.). At the 16-cell stage, micromeres were either
removed and discarded or transplanted onto host embryos in
defined positions. For transplants, all host micromeres were
removed and two donor micromeres were placed at the
vegetal pole in their place (McClay et al., 2000).Results
Fringe is most closely related to invertebrate Fringe
molecules
Fringe was cloned using a combination of PCR and
library screens. The conceptually translated protein is 410
amino acids in length (~47 kDa), which is similar to
Drosophila Fringe (Irvine and Wieschaus, 1994) and
vertebrate Lunatic Fringe (Johnston et al., 1997). Sequence
analysis suggests that Fringe contains a signal sequence for
entry into the secretory pathway with a cleavage site at the
33rd amino acid and a dibasic cleavage site at amino acid
110 (data not shown).
The translated Fringe protein was used for phylogenetic
analysis along with most identified Fringe molecules. This
protein phylogeny suggests that Fringe is most similar to the
single-copy Fringe proteins found in the invertebrates
Drosophila melanogaster, J. coenia, and S. gregaria (Fig.
2A). The protein phylogeny along with the absence of Manic
Fringe either in zebrafish and pufferfish genomic sequences
(R.E. Peterson, personal observation) further suggests that
the Manic Fringe family of proteins is more recently derived.
Fringe mRNA expression remains relatively constant during
germ layer development
Northern blot analysis and quantitative PCR (QPCR)
establish that fringe mRNA is maternally loaded and present
throughout development (Fig. 2B). QPCR results and North-
ern blot analysis show a slight and steady decrease in mRNA
until the hatched blastula stage, at which time mRNA levels
increase through late gastrula stage (Fig. 2C). Following this
mRNA, levels decrease as the pluteus stage is approached.
Mature Fringe appears in multiple locations in the cell
Antibodies against the bacterially expressed Fringe
mature peptide were produced in mouse, Guinea pig, and
R.E. Peterson, D.R. McClay / Developmental Biology 282 (2005) 126–137130
Fig. 3. Characterization of antibodies to Fringe. (A) Antibodies recognize a
doublet on Western blot analysis of embryonic proteins. Lane 1, chicken
anti-Fringe antiserum. Lane 2, Guinea pig anti-Fringe antiserum. Lane 3,
1D12 mouse monoclonal anti-Fringe. (B–G) Chicken polyclonal antiserum
staining of sea urchin embryos. (B) Late cleavage stage embryo showing
staining at the apical membrane and central punctate spot. (C) Cross-section
at early gastrula stage showing apical staining and central punctate spot.
(D) Affinity-purified antibody showing same basic pattern at mesenchyme
blastula stage. (E) Antibody preabsorbed with expressed Fringe shows a
loss of staining. (F) CMO-injected embryo stained to show Fringe
expression pattern at mesenchyme blastula stage. (G) Sister embryo,
injected with FMO stained in same procedure, showing large decrease in
Fringe stain.
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nant protein on Western blot analysis (data not shown) and
recognize a doublet in Urea-solubilized sea urchin embryos
(Fig. 3A). The apparent molecular weight of about 34 
103 Mr indicates that most Fringe is present in the ma-
ture form. Differential solubilization suggests that Fringe
is insoluble, being solubilized by 8 M Urea but not by
300 AM NaCl or 1% Triton X-100 (data not shown).
Recent reports demonstrate that Fringe proteins func-
tion in the Golgi apparatus (Hicks et al., 2000; Munro and
Freeman, 2000), though other reports suggest that Fringe
proteins could be secreted or at the cell surface (Johnston
et al., 1997; Ju et al., 2000; Wu et al., 1996). To
determine the sub-cellular distribution of Fringe, early
embryos were examined with each of the several anti-
bodies produced against a recombinant mature peptide.
With each antibody Fringe staining is detected at the
apical membrane (Figs. 3B,C) and as a prominent, central
punctate spot of antigen just beneath the apical cell
membrane (Figs. 3B,C). This intracellular spot of antigen
was described as the first location where newly glycosy-
lated proteins are seen in the cell (McClay and Wessel,
1984) and presumably represents the trans-Golgi network
or a late endosome compartment. Thus, Fringe protein is
located both in the Golgi and in surface membranes.
Partial affinity purification (Fig. 3D) and antibody
depletion (Fig. 3E) both provide added support for the
specificity of the FNG antibodies.
Fringe expression occurs initially in all cells then becomes
restricted during gastrulation
The distribution of Fringe protein was examined
throughout development. Antibody to the protein stains all
cells at early cleavage stages and this continues until the
PMCs lose Fringe at ingression (Fig. 4A). Shortly thereafter,
SMCs lose Fringe, and then, during gastrulation, endoderm
cells lose Fringe protein as they invaginate to form the
archenteron (Fig. 4B).
To confirm and better delineate the precise pattern of
Fringe expression during morphogenesis, embryos were
costained with other antibodies. Notch is lost from SMCs
following initial SMC specification and is increased in the
adjacent endoderm just before mesenchyme blastula stage,
resulting in a torus of Notch expression in the endoderm
(Fig. 4C; Parks et al., 2000; Sherwood and McClay, 1997;
summarized in Fig. 1). An SMC-specific antibody, SMC-1,
recognizes some or all SMCs in the vegetal plate before
they ingress (Sweet et al., 1999). Embryos triple-labeledFig. 2. Phylogeny of Fringe homologues and analysis of Fringe mRNA levels duri
proteins were aligned using PAUP. A distance tree was produced using 1000 Boots
points. (B) Northern blot analysis of poly (A) mRNA collected throughout develop
and probed with a fragment of fringe and L. pictus ubiquitin. (C) QPCR determ
different stages was determined by comparing the Threshold crossing point (Tc)
normalized to ubiquitin levels and the amount of mRNA present at egg stage wa
hatched blastula (H.B.), mesenchyme blastula (M.B.), early gastrula (E.G.), late gwith Fringe, Notch, and SMC-1 support the conclusion
that Fringe disappears from PMCs as they ingress,
but Fringe remains on the SMCs and endoderm until
gastrulation (Figs. 4C,D). These data indicate that all
Notch signaling must use Delta prior to ingression of the
PMCs since Fringe is present on the entire embryo. The
first time endoderm or SMCs become available for
signaling through any ligand other than Delta is in the
invaginated archenteron.
Loss of Fringe protein causes a decrease in secondary
mesenchyme cells and a block to gastrulation
A number of studies demonstrate that Delta and Notch
are necessary for SMC specification (McClay et al., 2000;
Sherwood and McClay, 1999; Sweet et al., 2002), andng embryogenesis. (A) Representatives of vertebrate and invertebrate Fringe
trapping replicates. Bootstrapping confidence levels are shown at the branch
ment. Equivalent amounts of mRNAwere run and blotted in adjacent lanes
ination of fringe relative levels. The amount of fringe mRNA present at
for fringe and ubiquitin from the same samples. The fringe levels were
s set to zero. Timepoints are Egg, 32-cell stage (32C), 60-cell stage (60C),
astrula (L.G.), and pluteus (PLU).
Fig. 5. Comparison of 600 AM and 300 AM MO-injected embryos. (A)
Control morpholino-injected (CMO) embryo (300 AM) with SMCs clearly
present at the tip of the archenteron (red arrowhead). (B) Fringe morpholino-
injected (FMO) embryo (300 AM) displaying a delay in gastrulation and a
lack of SMCs at the tip of the archenteron (red arrowhead). (C) Notch
morpholino-injected (NMO) embryo (300 AM) with delayed gastrulation
and no SMCs at the tip of the archenteron (red arrowhead). (D) CMO-
injected embryo (600 AM) with no delay in gastrulation, normal SMCs (red
arrow), and pigment cells (black arrow). (E) FMO-injected embryo (600
AM) with no gastrulation and no pigment cells. (F) NMO-injected embryo
(600 AM) with severely delayed gastrulation and no pigment cells
(arrowhead indicates small invaginated archenteron at the same age as the
control in panel D). (G) CMO-injected embryo (300 AM) at 48 h showing
normal skeletal structures. (H) FMO-injected embryo (300 AM) showing a
persistent loss of archenteron completion and some disruption in skeletal
patterning. (I) NMO-injected embryo (300 AM) showing eventual com-
pletion of archenteron and normal skeleton.
Fig. 4. Loss of Fringe expression during morphogenesis. (A) Early
mesenchyme blastula stage embryo with vegetal plate facing down.
Fringe is present at the apical membrane throughout the embryo except in
the PMCs that have ingressed (arrow). (B) Midgastrula stage embryo that
has undergone primary invagination and shows an absence of Fringe in
the SMCs (arrowhead) and endoderm (arrow). (C) Mesenchyme blastula
stage embryo stained with chick anti-Fringe (green), Guinea pig anti-
Notch (blue), and SMC-1 (red); arrowhead shows loss of Notch
expression in the vegetal plate while Fringe is still present. (D) Early-
gastrula stage embryo stained with the same antibodies; arrowhead
denotes SMCs stained with SMC-1 but lacking Fringe, while arrow
points out apical Notch in presumptive endoderm that does not express
Fringe.
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signal, we expected that a morpholino to fringe (FMO)
would eliminate SMCs. As a control, embryos injected with
300 AM FMO display very little Fringe protein compared to
control morpholino (CMO)-injected embryos (Figs. 3F,G).
Injection of 300 AM FMO results in a delay in gastrulation
and a loss of delaminating SMCs from the tip of the
archenteron (Fig. 5B). Notch MO leads to the same
phenotype (NMO; Fig. 5C) (Sherwood and McClay, 1999;
Sweet et al., 2002). At 600 AM, CMO embryos continue to
appear normal, while in embryos injected with FMO or
NMO, red pigment cells and invagination of the archenteron
are lost or greatly reduced (Figs. 5E–F). To quantify the loss
of pigment cells, CMO, NMO, and FMO were injected on
three separate occasions and the number of pigment cells
determined 48 h later. The results show a significant
decrease in pigment cell number with FMO and NMO
compared to CMO injection (Fig. 6). These data support the
conclusion that absence of Fringe results in a great reduction
of SMCs.
The two concentrations of FMO used (600 AM and
300 AM) have highly reproducible, yet different effects
on gastrulation. Embryos injected at the 600 AM level
fail to gastrulate (Fig. 5E), while those injected at 300
AM gastrulate after a significant delay but fail to complete
this process (Fig. 5H). Several markers were examined to
determine if endoderm specification is blocked in the 600
AM-injected eggs. Endo-1, an endodermmarker, is expressed
at the vegetal plate in embryos injected with 600 AM ofFMO (Figs. 8B), as is apical Notch (Fig. 9B). As described
above, apical Notch is present only in the presumptive
endoderm and remains there throughout gastrulation. Thus, at
least two markers normally found on specified endoderm
continue to be expressed.
Loss of Fringe delays ectoderm patterning
FMO-injected embryos (300 Am; Fig. 5H) also differ
from NMO-perturbed embryos by failing to form skeletal
barmsQ. Chimeric analyses were performed to determine
whether FMO injection affects the PMCs themselves or the
overlying ectoderm. Micromeres were swapped between
uninjected controls (Figs. 7A,B) and FMO-injected embryos
(Figs. 7C,D). Micromeres bearing FMO produced PMCs
that made a normal skeleton after being combined with
micromereless control hosts (Figs. 7E,F; n = 24). Recip-
rocally, normal micromeres produce a normal skeleton when
placed on a micromereless host injected with FMO,
although the appearance of arms is delayed (Figs.
Fig. 6. Pigment cell counts. Pigment cells were counted at 48 h in thirty
embryos injected with CMO, FMO, or NMO. Three separate tests were
conducted and the SD determined for each thirty-sample set.
Fig. 7. Chimera analysis between FMO and uninjected embryos. (A,B)
Uninjected embryos and (C,D) 600 AM FMO injected embryos here shown
at 24 h were used as donors of micromeres to micromereless embryos of the
opposite type. (E,F) FMO-containing PMCs (green) form a normal skeleton
when combined with an uninjected (red) micromereless host. (G,H)
Uninjected control PMCs (red) form a delayed skeleton when placed on
an FMO-injected micromereless host (green). The FMO-injected hosts are
albino or contain few pigment cells, though by 24 h partial archenteron
morphogenesis occurs.
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is not due to a Fringe-related failure in PMCs, but to a
delay in the overlying cells of the embryo to provide
adequate patterning information. Evidence from previous
studies showed that positional information from the
ectoderm is necessary for the patterning of skeletogenesis
(Armstrong and McClay, 1994; Armstrong et al., 1993),
and the PMCs initially form a ring at inside the boundary
of the endoderm and ectoderm. Thus, another conse-
quence of Fringe perturbation is the delay in cells in this
region to provide the correct signals for skeletogenesis to
proceed normally.
To ask if consequences of Fringe perturbations alter
ectoderm specification, markers of ectoderm specification
were examined. EctoV normally is expressed in all cells
of the epithelium until the gastrula stage, at which point
the labeling continues to be expressed in the oral
ectoderm, stomodeum, and foregut, but is lost from
aboral ectoderm and the remaining parts of the endoderm
(McClay and Wessel, 1984; Fig. 8C). In 600 AM FMO-
injected embryos, the EctoV staining is reduced but not
lost from the aboral region indicating at a delay orFig. 8. Staining of CMO and FMO-injected embryos with markers of
endoderm and ectoderm specification. (A,C,E) CMO-injected embryos.
(B,D,F) FMO-injected embryos. (A) EndoI-stained control showing the
large midgut with the hindgut positioned below. (B) An FMO-injected
embryo showing a patch of EndoI staining at the vegetal pole. (C) EctoV
stained embryo with expression found throughout the oral ectoderm.
(D) FMO-injected embryo stained with EctoV showing expression
throughout the blastoderm with only an incremental drop in half the
embryo. (E) UH-295 stain outlining the ciliary band of a CMO-injected
embryo. (F) FMO-injected embryo with UH-295 expression expanded in
the thickened animal cap.
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295 monoclonal antibody stains the ciliary band separat-
ing the oral and aboral ectoderm compartments. In
control embryos, the ciliary band is stained as expected
(Fig. 8E), but in 600 AM FMO-injected embryos, UH-
295 expression expands to cover more ectoderm in the
most severe cases or is delayed in forming a ciliary band
in less severe cases (Fig. 8F). Both markers indicate a
failure to specify oral and aboral ectoderm in the normal
time, but the results of Fig. 7 indicate that correct oral–
aboral patterning information is provided to PMCs.
Previous studies showed that Notch signaling has an
impact on specification at the endoderm/ectoderm boun-
dary (Sherwood and McClay, 2001). Since loss of Fringe
delayed ectoderm patterning, we next examined whether
the Fringe effect on ectoderm might be due to some
modification of the boundary. As a marker for ectoderm/
endoderm boundary formation, nuclear h-catenin delin-
eates the endodermal side of the boundary (Fig. 9E; Logan
et al., 1999; Sherwood and McClay, 2001). SoxB1 is
retained by ectoderm cells as they are specified and thus
was used as an additional marker (Fig. 9E; Kenny et al.,
1999; Angerer and Angerer, 2003). Injection of FMOFig. 9. An ectoderm/endoderm boundary forms in MO-injected embryos.
(A) CMO-injected embryo stained with a PMC marker (1D5, red), anti-
Notch (blue), and anti-SoxB1 (green). (B) FMO-injected embryo stained
with the same antibody mixture. (C) Embryo injected at the two-cell stage
with CMO and visualized with DIC microscopy. (D) Embryo injected at the
two-cell stage with FMO and visualized with DIC microscopy. (E) Embryo
injected with CMO then fixed at 15 h and costained with h-catenin (red)
and SoxB1 (green). (F) Embryo injected with FMO then fixed at 15 h and
costained with h-catenin (red) and SoxB1 (green). Red arrowheads point to
nuclear h-catenin staining that delineates the ectoderm/endoderm boundary.results in a decrease in SoxB1 expression throughout the
embryo (Fig. 9B) unlike the pattern seen in CMO-injected
controls (Fig. 9A). Specification of PMCs appears normal.
Injection of FMO at the two-cell stage allows visualization
of the effect with a control vs. experimental half in the
same embryo. The FMO-injected half-embryo fails to
gastrulate (Fig. 9D), fails to retain the SoxB1 protein in the
animal half (Fig. 9F), and appears to lose any sign of an
ectoderm–endoderm boundary on the injected side (Fig.
9F). Though details of the ectoderm gene regulatory
network are not known, Notch signals relying on Fringe
appear necessary. The thickened cells on the injected side
suggest also a slow down in the division of the cells on the
side injected with morpholino. The Fringe MO phenotype
is different from the published phenotypes reported using
dominant-negative Notch expression (Sherwood and
McClay, 1999), in that endoderm, and at the higher
concentration, ectoderm, are affected in addition to SMC
specification. In an earlier report, a Delta MO was shown
to partially block SMC specification but had no apparent
effect on endoderm invagination (Sweet et al., 2002).
Given these data, either the Fringe-MO knockdown was
more complete than either the Delta or Notch perturbations
or Fringe somehow interfered with processes beyond the
known Notch modifications. To address this issue, we
asked if a more complete Notch knockdown approached
the Fringe-MO phenotype. Accordingly, we asked if a
combination of injections using 300 AM NMO and
dominant-negative notch mRNA would have a more severe
phenotype than the NMO alone. Compared to control
embryos (Fig. 10A), embryos injected with either NMO
alone (Fig. 10B) or NMO and a notch control mRNA (Fig.
10C) display a slight delay in gastrulation and a nearly
normal pluteus that lack pigment cells (Figs. 10F,G).
However, injection of NMO and dominant-negative notch
mRNA together causes a more severe blockage of
gastrulation (Fig. 10D), from which most embryos do
not recover (Fig. 10H). Thus, a more complete Notch
knockdown phenocopies the Fringe-MO embryos.Discussion
Mesoderm in the sea urchin is specified in the most
vegetal region, endoderm is specified above, and ectoderm
specification occurs throughout the animal half of the
embryo (Angerer and Angerer, 1997; Logan and McClay,
1997). The Notch signaling pathway is involved in
specification decisions that first separate the SMCs from
endomesoderm and then in the separation of two different
SMC populations (Sherwood and McClay, 1999; Sweet
et al., 2002). Data from this and other studies also suggest
that a Notch signal, requiring Fringe, is involved in
endoderm specification and in boundary formation bet-
ween the ectoderm and endoderm (Davidson et al., 2002;
Sherwood and McClay, 2001). Other earlier studies may
Fig. 10. Combinatorial injection of LvNneg and NMO. (A–D) Embryos imaged at 24 h. (E–H) Embryos imaged at 48 h. (A and E) Embryos injected with 300
AM CMO. (B and F) Embryos injected with 300 AM NMO. (C and G) Embryos injected with both 300 AM NMO and 5.0 pg/pL LvNnegD. (D and H) Embryos
injected with both 300 AM NMO and 4.5 pg/pL LvNneg.
R.E. Peterson, D.R. McClay / Developmental Biology 282 (2005) 126–137 135have missed these additional Notch signal phenotypic
consequences because of an incomplete depletion of Notch
or Delta function.
Fringe protein is expressed at the cell surface until the onset
of morphogenesis
A mouse monoclonal and several polyclonal anti-
bodies from chicken and guinea pig were produced to
examine the expression of Fringe. The antibodies all
recognize the recombinant protein, give the same staining
pattern on immunoblots of endogenous protein or of
expressed protein, and at a molecular weight predicted
from the sequence information (Fig. 3). Affinity purifi-
cation and protein preabsorption of the chicken poly-
clonal antibodies support their specificity (Fig. 3), and a
morpholino to Fringe largely eliminates the Fringe
staining. The antibodies stain both a trans-Golgi network
compartment and the membrane supporting its role as a
glycosyltransferase that modifies Notch. Fringe initially is
expressed by all cells of the embryo but disappears from
cells as they undergo morphogenesis. Fringe disappears
from the SMCs where Notch has signaled shortly before
primary invagination of the archenteron. Notch itself
disappeared from these areas earlier (Sherwood and
McClay, 1997). Fringe later disappears from endoderm
as it invaginates, though in endoderm Notch remains on
the cell surface.
Fringe is required for SMC specification
Experiments using FMO injection in comparison with
NMO and CMO injections verify that Fringe-modified
Notch is necessary for the specification of SMCs.
Without Fringe, there is an almost complete loss of
pigment cells and of delaminating cells from the tip of
the invaginating archenteron (Fig. 5), well-documentedfeatures of SMC-less embryos. The few remaining pigment
cells may be due to an extended presence of maternal
Fringe protein, and this is supported by the antibody
staining from FMO injections in which small amounts of
Fringe remain on cells (Fig. 3G). Since Fringe-modified
Notch is imperative for signaling through Delta and a
normal Delta signal is produced by the micromeres, this
signal cannot be transduced when zygotic Fringe is
unavailable to glycosylate Notch in the FMO-injected
embryos.
Archenteron invagination requires a Fringe-modified Notch
signal
Sherwood and McClay (2001), Sweet et al. (2002), and
Davidson et al. (2002) suggest that a Notch–Delta signal
plays some role in the specification of endoderm.
However, neither injection of dominant-negative Notch
mRNA (Sherwood and McClay, 1999) nor Delta MO
injections (Sweet et al., 2002) result in a significant loss
of endoderm. Our data show that loss of Fringe also does
not completely block endoderm specification, since
several protein markers are still expressed (Figs. 8A,B,
9A,B), but the archenteron fails to invaginate and
complete its morphogenesis. The failure to invaginate is
a more severe phenotype than that which occurs with
injection of Notch dominant-negative alone or NMO
alone. Sweet et al. (2002) describe their Delta-MO
knockdown as being incomplete even when they used
very high concentrations of morpholino (about 6 times
higher than the highest concentration of FMO used). The
FMO phenotype was matched when maternal and zygotic
Notch were perturbed simultaneously (Fig. 10). Together,
these data suggest that the Fringe phenotype demonstrates
a requirement for a Notch–Delta signal both for SMC
specification and for later endoderm specification prior to
morphogenesis.
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consequence of loss of Notch signaling
Fringe is expressed throughout the ectoderm, which
means that Delta would have to serve as the ligand if Notch
were to be activated there (Serrate cannot be activated by
Fringe-modified Notch). However, Delta is never expressed
directly in, or adjacent to, the ectoderm (Sweet et al., 2002).
Thus, Notch is not activated directly in the ectoderm, in part
since the low initial levels of Notch found in the ectoderm
eventually disappear (Sherwood and McClay, 1997), and
because Fringe is expressed throughout the ectoderm, Notch
cannot signal through Serrate (Serrate-like sequences are in
the sea urchin genome, but because of the way Fringe
functions, Serrate could not signal in ectoderm even if
present in that location). How then might the double
Notch perturbations and the Fringe morpholino delay
ectoderm specification and/or patterning? The data of
Hfrstadius and Wikramanayake and others (Horstadius,
1939; Logan and McClay, 1999; Wikramanayake and
Klein, 1997; Wikramanayake et al., 1995) show that a
signal from the veg1 layer is required for oral/aboral
segregation in the ectoderm. Data from this laboratory
show that veg1 is at least partially patterned by a signal
from veg2 (Logan and McClay, 1999). Thus, the likely
possibility is that the vegetal signal required for oral/aboral
specification is delayed, resulting in a large delay in oral–
aboral patterning, though that patterning eventually occurs.
It is also possible that Fringe in the ectoderm normally
modifies another protein, but recorded activities of Fringe
in every system studied so far are restricted to Notch-
related signaling.
The sea urchin relies on a cascade of signals beginning at
the vegetal pole and working towards the animal pole, cell-
by-cell (Davidson, 1989; Davidson et al., 1998). The results
presented here and the results of others show that Notch
activation functions at several important junctures, and these
result in SMC specification, and later in endoderm spe-
cification necessary for primary invagination of the arch-
enteron. Careful analysis of Notch activation and other Notch
modifiers will be necessary to determine more precisely the
sequence of specification events that result from each of these
Notch-impacted developmental events. Of importance, the
Fringe data show that Notch–Delta is responsible for a broad
suite of developmentally significant specification events,
which reinforces its position high in the specification
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